Euroapi Company Header Euroapi Company Header

X

Find the latest news about Shionogi aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Shionogi
japan Flag
Country
Country
Japan
Address
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045
Telephone
Telephone
+81-6-6202-2161
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240718966472/en

BUSINESSWIRE
18 Jul 2024

https://www.biospectrumasia.com/news/25/24407/japans-shionogi-inks-400-m-deal-with-french-firm-cilcare-to-address-hearing-loss.html

BIOSPECTRUM ASIA
10 Jun 2024

https://www.businesswire.com/news/home/20240603607289/en

BUSINESSWIRE
03 Jun 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/japans-shionogi-says-covid-treatment-did-not-meet-endpoint-late-stage-trial-2024-05-13/

REUTERS
13 May 2024

https://www.biopharmadive.com/news/maze-shionogi-pompe-drug-deal-ftc-sanofi/715751/#:~:text=Now%20Maze%2C%20only%20five%20months,said%20Coloma%2C%20in%20a%20statement.

Ben Fidler BIOPHARMADIVE
11 May 2024

https://www.businesswire.com/news/home/20240509209338/en

BUSINESSWIRE
10 May 2024

https://www.prnewswire.com/news-releases/approximately-usd-10-8-million-invested-in-new-drug-development-for-malaria-and-ntds-in-partners-including-japanese-pharma-shionogi-mitsubishi-tanabe-and-eisai-and-europe-based-institutions-302140073.html

PR NEWSWIRE
09 May 2024

https://www.pharmaceutical-technology.com/news/ghit-fund-malaria-ntd-drug-development/

PHARMACEUTICAL TECHNOLOGY
09 May 2024

https://www.businesswire.com/news/home/20240430639511/en

BUSINESSWIRE
30 Apr 2024

https://www.businesswire.com/news/home/20240418017364/en

BUSINESSWIRE
18 Apr 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY